Literature DB >> 15497970

Design and efficient synthesis of 2 alpha-(omega-hydroxyalkoxy)-1 alpha,25-dihydroxyvitamin D3 Analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity.

Nozomi Saito1, Yoshitomo Suhara, Masaaki Kurihara, Toshie Fujishima, Shinobu Honzawa, Hitoshi Takayanagi, Toshiro Kozono, Masahiko Matsumoto, Masayuki Ohmori, Naoki Miyata, Hiroaki Takayama, Atsushi Kittaka.   

Abstract

A concise and efficient synthetic approach to 2 alpha-(omega-hydroxyalkoxy)-1 alpha,25-dihydroxyvitamin D(3) (4a-c), including 2-epi-ED-71, was developed starting from D-glucose as a chiral template for the construction of the 2 alpha-modified A-ring precursors (11a-c). It was found that the best ligand for the bovine thymus vitamin D receptor (VDR) in this series is 4b, which has 1.8 times greater binding affinity for the bovine thymus VDR than that of the natural hormone 1. Interestingly, potency in the induction of HL-60 cell differentiation for 4a-c was almost the same or weaker than that of 1 despite the strong binding affinity for the VDR. Next, we were interested in the "double modification"of 1 based on 4a-c with C20-epimerization, affording 2 alpha-(omega-hydroxyalkoxy)-20-epi-1 alpha,25-dihydroxyvitamin D(3) (20-epi-4a-c). All three 2 alpha-substituted 20-epi analogues of 1 (20-epi-4a-c) exhibited stronger binding affinities for the VDR, and their conformations in the ligand binding domain of VDR were analyzed by molecular modeling. Double-modified analogues of 20-epi-4a-c showed marked HL-60 cell differentiation activity, and 20-epi-4a possesses an activity 58-fold higher than that of the natural hormone 1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497970     DOI: 10.1021/jo0491051

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Synthesis of 2α-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo.

Authors:  Miki Matsuo; Asami Hasegawa; Masashi Takano; Hiroshi Saito; Shinji Kakuda; Takayuki Chida; Ken-Ichiro Takagi; Eiji Ochiai; Kyohei Horie; Yoshifumi Harada; Midori Takimoto-Kamimura; Kazuya Takenouchi; Daisuke Sawada; Atsushi Kittaka
Journal:  ACS Med Chem Lett       Date:  2013-05-28       Impact factor: 4.345

2.  Novel vitamin d analogs for prostate cancer therapy.

Authors:  Tai C Chen; Atsushi Kittaka
Journal:  ISRN Urol       Date:  2011-09-19

Review 3.  Development of In Vitro and In Vivo Evaluation Systems for Vitamin D Derivatives and Their Application to Drug Discovery.

Authors:  Kaori Yasuda; Miyu Nishikawa; Hiroki Mano; Masashi Takano; Atsushi Kittaka; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

4.  Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats.

Authors:  Miyu Nishikawa; Naruhiro Murose; Hiroki Mano; Kaori Yasuda; Yasuhiro Isogai; Atsushi Kittaka; Masashi Takano; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.